NHS to offer new injectable cancer immunotherapy, reducing hospital stays
Thousands of patients will be offered a new injectable form of an immunotherapy drug that can be administered in minutes rather than lengthy infusions. The NHS expects the change to cut hospital time by several hours and improve patient experience.
Advertisement: Article Inline